OPTIONS FOR MANAGING PSYCHOTROPIC MEDICATIONS IN DRUG-ABUSING PATIENTS PARTICIPATING IN BEHAVIORAL THERAPIES CLINICAL TRIALS

Ítems similars

• "RESEARCH" VERSUS "REAL-WORLD" PATIENTS: REPRESENTATIVENESS OF PARTICIPANTS IN CLINICAL TRIALS OF TREATMENTS FOR COCAINE DEPENDENCE
  per: CARROLL, K.M
  Publicat: (1999)
• STAFF BELIEFS ABOUT DRUG ABUSE CLINICAL TRIALS
  per: FORMAN, R.F
  Publicat: (2002)
• PROTECTION OF PARTICIPANTS AND EXPERIMENTAL DESIGN IN CLINICAL ABUSE LIABILITY TESTING
  per: MENDELSON, J.H
  Publicat: (1992)
• THE ETHICAL CONDUCT OF CLINICAL TRIALS OF HIV VACCINES
  per: MARINER, W.K
  Publicat: (1991)
• UTILITY OF CROSSOVER DESIGNS IN CLINICAL TRIALS: EFFICACY OF DESIPRAMINE VS. PLACEBO IN OPIOID-DEPENDENT COCAINE ABUSERS
  per: FEINGOLD, A.
  Publicat: (2002)